Clinical and Experimental Reproductive Medicine

The Korean Society for Reproductive Medicine (대한생식의학회)
권호 표지

The Preconceptional Level of Peripheral Natural Killer Cells which was Expected to Bring Successful Treatment Outcome using Low-dose Intravenous Gamma Immunoglobulin (IVIg) Infusion in Patients with Recurrent Spontaneous Abortion

습관성 유산 환자에서 저용량 면역글로불린 치료와 말초혈액 내 Natural Killer (NK) 세포의 임계치에 관한 연구

  • Cha, Sun Hwa (Department of Obstetrics and Gynecology, Samsung Cheil Hospital & Women's Healthcare Center Sungkyunkwan University School of Medicine) ;
  • Kim, Hae Suk (Department of Obstetrics and Gynecology, Samsung Cheil Hospital & Women's Healthcare Center Sungkyunkwan University School of Medicine) ;
  • Kim, Hye Ok (Department of Obstetrics and Gynecology, Samsung Cheil Hospital & Women's Healthcare Center Sungkyunkwan University School of Medicine) ;
  • Song, In Ok (Department of Obstetrics and Gynecology, Samsung Cheil Hospital & Women's Healthcare Center Sungkyunkwan University School of Medicine) ;
  • Yoo, Keun Jai (Department of Obstetrics and Gynecology, Samsung Cheil Hospital & Women's Healthcare Center Sungkyunkwan University School of Medicine) ;
  • Koong, Mi Kyung (Department of Obstetrics and Gynecology, Samsung Cheil Hospital & Women's Healthcare Center Sungkyunkwan University School of Medicine) ;
  • Kang, Inn Soo (Department of Obstetrics and Gynecology, Samsung Cheil Hospital & Women's Healthcare Center Sungkyunkwan University School of Medicine) ;
  • Yang, Kwang Moon (Department of Obstetrics and Gynecology, Samsung Cheil Hospital & Women's Healthcare Center Sungkyunkwan University School of Medicine)
  • 차선화 (성균관대학교 의과대학, 삼성제일병원 산부인과 불임 및 생식내분비) ;
  • 김해숙 (성균관대학교 의과대학, 삼성제일병원 산부인과 불임 및 생식내분비) ;
  • 김혜옥 (성균관대학교 의과대학, 삼성제일병원 산부인과 불임 및 생식내분비) ;
  • 송인옥 (성균관대학교 의과대학, 삼성제일병원 산부인과 불임 및 생식내분비) ;
  • 유근재 (성균관대학교 의과대학, 삼성제일병원 산부인과 불임 및 생식내분비) ;
  • 궁미경 (성균관대학교 의과대학, 삼성제일병원 산부인과 불임 및 생식내분비) ;
  • 강인수 (성균관대학교 의과대학, 삼성제일병원 산부인과 불임 및 생식내분비) ;
  • 양광문 (성균관대학교 의과대학, 삼성제일병원 산부인과 불임 및 생식내분비)
  • Published : 2005.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: We aimed to investigate the clinical effect of low-dose intravenous immunoglobulin treatment in unexplained recurrent spontaneous aborters (RSA) with elevated peripheral CD56+ natural killer (NK) cell levels and to determine the pre-conceptional NK cell percentage predictive of subsequent successful pregnancy outcome. Materials and Methods: Sixty four cases of unexplained recurrent miscarriage with elevated peripheral NK cells (>15%) were received low dose IVIg infusion at the dosage of 400 mg/Kg/month after confirmation of gestational sac and continued until 20 weeks. The patients were divided into two groups according to the pregnancy outcome: Group I was success of treatment defined as live birth at or after 25 gestational weeks and Group II was failure of treatment. The preconceptional levels of the peripheral blood NK cells were compared between two groups. Results: Fifty-three pregnancies resulted in live births after 25 weeks and 11 resulted in abortion (Overall success rate of IVIG treatment was 82.8%). Preconceptional CD56+ NK cell percentage in group II ($27.4{\pm}1.9%$) was higher than those in group I ($22.3{\pm}0.8%$). By using ROC curve, optimal discrimination between success and failure of treatment was achieved with ${\leq}27%$ of preconceptional NK cell percentage. Conclusion: In RSA patients with elevated NK cells, we suggest that preconceptional peripheral blood CD56+ NK cell level could be a useful marker for predicting successful treatment outcome of low-dose IVIg infusion.

Keywords

References

  1. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternalfetal relationship: Is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14: 353-6 https://doi.org/10.1016/0167-5699(93)90235-D
  2. Higuchi K, Aoki K, Kimbara T, Hosoi N, Yamamoto T, Okada H. Suppression of natural killer cell activity by monocytes following immunotherapy for recurrent spontaneous aborters. Am J Reprod Immunol 1995;33: 221-7 https://doi.org/10.1111/j.1600-0897.1995.tb00888.x
  3. Kwak JY, Beaman KD, Gilman-Sachs A, Ruiz JE, Schewitz D, Beer AE. Up-regulated expression of CD56+, CD56+/CD16+, and CD19+ cells in peripheral blood lymphocytes in pregnant women with recurrent pregnancy losses. Am J Reprod Immunol 1995;34: 93-9 https://doi.org/10.1111/j.1600-0897.1995.tb00924.x
  4. Beer AE, Kwak JY, Ruiz JE. Immunophenotypic profiles of peripheralblood lymphocytesin women with recurrent pregnancy losses and in infertile women with multiple failed in vitro fertilization cycles. Am J Reprod Immunol 1996;35: 376-82 https://doi.org/10.1111/j.1600-0897.1996.tb00497.x
  5. Clark DA, Coulam CB. Is there an immunological cause of repeated pregnancy wastage? Adv Obstet Gynecol 1995;3: 321-42
  6. Yamada H, Morikawa M, Kato EH, Shimada S, Kobashi G, Minakarni H. Pre-conceptional naturalkiller-cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with normal chromosome karyotype. Am J Reprod Immunol 2003; 50: 351-4 https://doi.org/10.1034/j.1600-0897.2003.00095.x
  7. Aoki K, Kajiura S, Matsumoto Y, Ogasawara M, Okada S, Yagami Y, et al. Preconceptional naturalkiller-cell activity as a predictor of miscarriage. Lancet 1995;345: 1340-2 https://doi.org/10.1016/S0140-6736(95)92539-2
  8. Emmer PM, Veerhoek M, Nelen WL, Steegers EA, Joosten I. Natural killer cell reactivity and HLA-G in recurrent spontaneous abortion. Transplant Proc 1999; 31: 1838-1840
  9. Kwak JY, Kwak FM, Ainbinder SW, Ruiz AM, Beer AE. Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions. Am J Reprod Immunol 1996; 35: 363-9 https://doi.org/10.1111/j.1600-0897.1996.tb00495.x
  10. Ruiz JE, Kwak JY, Baum L, Gilman-Sachs A, Beaman KD, Kim YB, et al. Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortion. Am J Reprod Immunol 1996; 35: 370-5 https://doi.org/10.1111/j.1600-0897.1996.tb00496.x
  11. Coulam CB, Krysa L, Sterm J, Bustillo M. Intravenous immunoglobulin for treatment of recurrent pregnancy loss. Am J Reprod Immunol 1995; 34: 333-7 https://doi.org/10.1111/j.1600-0897.1995.tb00960.x
  12. Christiansen OB, Mathiesen O, Husth M, Ramsussen KL, Ingersler HJ, Lauristen JG, et al. Placebocontrolled trial of treatment of unexplained secondary recurrent spontaneous abortion with i.v, immunoglobulin. Hum Reprod 1995; 10: 2690-5
  13. Intravenous immunoglobulin in the prevention of recurrent miscarriage. The German RSA/IVIG Group [editorial]. Br J Obstet Gynaecol 1994; 101: 1072-7. https://doi.org/10.1111/j.1471-0528.1994.tb13584.x
  14. Stephenson MD, Dreher K, Houlihan E, Wu V. Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double, blinded, placebo controlled trial. Am J Reprod Immunol 1998; 39: 82-8 https://doi.org/10.1111/j.1600-0897.1998.tb00339.x
  15. 김문영, 양광문, 김해숙, 차선화, 궁미경, 강인수 등. 말초혈액 CD56+ Natural Killer cell의 증가에 기인하여 면역글로불린 치료 후 분만한 습관성 유산 환자에서 향후 계획 임선 전 시행한 말초혈액 NK cell의 변화에 대한 연구. 대한산부회지 2004; 47: 1926-30
  16. 차선화, 양광문, 박찬우, 김해숙, 조동희, 강인수, 궁미경 등 말초혈액 CD56+ Natural Killer Cell 증가에 기인한 습관성 유산 환자에서 정맥 내 면역글로블린 치료의 효과에 관한 연구, 대한불임학회지 2005; 32: 165-70
  17. Szekeres-Bartko J, Faust Z, Varga P, Szereday L, Kelemen K. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokene production. Am J Reprod Immunol 1996; 35: 348-57 https://doi.org/10.1111/j.1600-0897.1996.tb00492.x
  18. Ribbing SL, Hoverland RC, Beaman KD. T-cell suppressor factor play an integral role in preventing fetal rejection. J Reprod Immunol 1988; 14: 83-95 https://doi.org/10.1016/0165-0378(88)90038-1
  19. Nichols TC, Kang J, Angkachatchai V, Beer AE, Beaman KD. Expression of a membrane form of the pregnancy associated protein TJ6 on lymphocytes. Cell Immunol 1994; 155: 219-29 https://doi.org/10.1006/cimm.1994.1114
  20. Beaman KD, Angkahatchai V, Gilman-Sacks A. TJ6: The pregnancy-associated cytokine. Am J Reprod Immunol 1996; 35: 338-41 https://doi.org/10.1111/j.1600-0897.1996.tb00490.x
  21. Clark DA, Vince G, Flanders KC, Hirte H, Starkey P. CD56+ lymphoid cells in human first trimester pregnancy decidua as a source of novel TGF-$beta$2-related immunosuppressive factors. Hum Reprod 1994; 9: 2270-7
  22. Yokoyama M, Sano M, Sonoda K, Nozaki M, Nakamura GI, Nakano H. Cytotoxic cells directed against placental cells detected in human habitual abortions by an in vitro terminal labeling assay. Am J Reprod Immunol 1994;31: 197-204 https://doi.org/10.1111/j.1600-0897.1994.tb00867.x
  23. Ruiz JE. Effect of intravenous immunoglobulin on natural killer cell activity in women with recurrent spontaneous abortion. Master thesis, Finch university of health sciences/The chicagomedical school, United states; 1995
  24. Kwak JY, Kwak FM, Gilman-Sachs A, Beaman KD, Cho DD, Beer AE. Immunoglobulin G infusion treatment for women with recurrent spontaneous abortions and elevated CD56+ Natural killer cells. Early pregnancy 2000; 4: 154-64
  25. Morikawa M, Yamada H, Kato EH, Shimada S, Kishi T, Yamada T, et al. Massive intravenous immunoglobulin treatment in women with four or more recurrent spontaneous abortions of unexplained etiology: down-regulation of NK cell activity and subsets. Am J Reprod Immunol 2001; 46: 399-404 https://doi.org/10.1034/j.1600-0897.2001.d01-31.x